Contact: Jules Asher
NIH/National Institute of Mental Health
Caption: Over several trials, participants were required to attend to either the identity (non-emotional feature) or the emotion of a face, remember it during a 9-second delay, and match the feature to a subsequent face. Neural activity in the visual cortex elicited by the emotion trials predicted depressed patients' subsequent responsiveness to scopolamine treatment.
Credit: Maura Furey, Ph.D., NIMH Experimental Therapeutics and Pathophysiology Branch
Usage Restrictions: None
Related news release: Imaging biomarker predicts response to rapid antidepressant